{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-026758","form_type":"8-K","ticker":"AGL","cik":"0001831097","company_name":"agilon health, inc.","filed_at":"2024-06-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.507248+00:00","generated_at":"2026-06-01T06:19:58.609163+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"agilon health appoints Jeff Schwaneke as CFO, replacing retiring Tim Bensley effective July 1, 2024","bullets":["Jeff Schwaneke, former Centene CFO (2016-2021) and EVP Health Care Enterprises, named CFO and EVP effective July 1, 2024.","Schwaneke steps down from agilon board; compensation includes $625K base salary, 75% target bonus, $2.5M RSUs, $1M PSUs with 100% share price hurdle, plus $300K cash sign-on.","Timothy Bensley announced earlier retirement in early 2024 and will remain through a transition period.","Schwaneke brings 27+ years finance experience, including 15 in managed care; Centene revenues grew from $20B to $125B during his CFO tenure."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-026758","json":"https://secwatch.observer/filing/0001628280-24-026758.json","markdown":"https://secwatch.observer/filing/0001628280-24-026758.md","text":"https://secwatch.observer/filing/0001628280-24-026758.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831097/000162828024026758/0001628280-24-026758-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831097/000162828024026758/agl-20240604.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T06:19:58.609163+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0c3ba77b32","claim":"Jeff Schwaneke resigned as Director at agilon health, inc..","evidence_excerpt":"In connection with his appointment, Mr. Schwaneke will resign from the agilon health, inc. Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831097/000162828024026758/0001628280-24-026758-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b57c9cdf17","claim":"Jeff Schwaneke was appointed as Chief Financial Officer and Executive Vice President at agilon health, inc..","evidence_excerpt":"On June 4, 2024, agilon health, inc. (the “Company”) appointed Jeff Schwaneke to serve as the Company’s Chief Financial Officer and Executive Vice President effective July 1, 2024 (the “Effective Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831097/000162828024026758/0001628280-24-026758-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer and Executive Vice President"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}